La vendita allo scoperto per Verona Pharma dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Verona Pharma. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Verona Pharma (NASDAQ:VRNA) Azioni, Report sulle vendite allo scoperto

VERONA PHARMA PLC - ADR

Verona Pharma

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

CPRX

VRNA

Scopriamo i 3 titoli sanitari che potrebbero affrontare un crollo a causa di indicatori di mercato e RSI elevati.

Scopri i 3 titoli sanitari che potrebbero crollare ad agosto

Verona Pharma plc - American Depositary Shares

Verona Pharma PLC

Macro Economic Events

Macro Notification

Econ #s

Economics

General

USA 30-Year Bond Auction 4.813% Vs 4.623% Prior

Analyst Ratings

CRWD

HOOD

PANW

VRTX

UPDATE: CNBC Halftime Report Final Trades: Vertex Pharmaceuticals, Robinhood Markets, Palo Alto Networks, CrowdStrike Holdings

<p>Financial giants have made a conspicuous bullish move on Riot Platforms. Our analysis of options history for Riot Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) revealed 8 unusual trades.</p>
<p>Delving into the details, we found 50% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $180,150, and 2 were calls, valued at $76,868.</p>
<h3>Projected Price Targets</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $5.5 to $10.0 for Riot Platforms during the past quarter. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In terms of liquidity and interest, the mean open interest for Riot Platforms options trades today is 5581.0 with a total volume of 2,904.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Riot Platforms's big money trades within a strike price range of $5.5 to $10.0 over the last 30 days.</p>
<h3>Riot Platforms Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1744304441_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.27</td>
<td>$1.2</td>
<td>$1.21</td>
<td>$10.00</td>
<td>$46.2K</td>
<td>18.7K</td>
<td align="right">465</td>
</tr>
<tr>
<td>RIOT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$1.8</td>
<td>$1.75</td>
<td>$1.75</td>
<td>$8.50</td>
<td>$43.7K</td>
<td>379</td>
<td align="right">1</td>
</tr>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$1.54</td>
<td>$1.53</td>
<td>$1.54</td>
<td>$5.50</td>
<td>$30.6K</td>
<td>325</td>
<td align="right">208</td>
</tr>
<tr>
<td>RIOT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$1.17</td>
<td>$1.14</td>
<td>$1.14</td>
<td>$8.00</td>
<td>$28.5K</td>
<td>6.3K</td>
<td align="right">478</td>
</tr>
<tr>
<td>RIOT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$1.17</td>
<td>$0.97</td>
<td>$1.14</td>
<td>$8.00</td>
<td>$28.5K</td>
<td>6.3K</td>
<td align="right">476</td>
</tr>
</tbody>
</table>
</p>
<h3>About Riot Platforms</h3>
<p>Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.</p>
<h3>Riot Platforms's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 10,532,232, the RIOT's price is down by -3.98%, now at $7.08. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 20 days.</li>
</ul>
<h3>Expert Opinions on Riot Platforms</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $13.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from JP Morgan persists with their Overweight rating on Riot Platforms, maintaining a target price of $13. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Riot Platforms with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Options

RIOT

Behind the Scenes of Riot Platforms's Latest Options Trends

<p>Deep-pocketed investors have adopted a bullish approach towards 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MMM usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 15 extraordinary options activities for 3M. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 53% leaning bullish and 46% bearish. Among these notable options, 12 are puts, totaling $1,016,438, and 3 are calls, amounting to $141,755.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $120.0 to $170.0 for 3M over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for 3M's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across 3M's significant trades, within a strike price range of $120.0 to $170.0, over the past month.</p>
<h3>3M 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1744304436_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MMM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$15.6</td>
<td>$15.15</td>
<td>$15.35</td>
<td>$145.00</td>
<td>$116.7K</td>
<td align="right">870</td>
<td align="right">231</td>
</tr>
<tr>
<td>MMM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$15.6</td>
<td>$15.05</td>
<td>$15.35</td>
<td>$145.00</td>
<td>$116.1K</td>
<td align="right">870</td>
<td align="right">154</td>
</tr>
<tr>
<td>MMM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$15.65</td>
<td>$15.15</td>
<td>$15.15</td>
<td>$145.00</td>
<td>$115.4K</td>
<td align="right">870</td>
<td align="right">385</td>
</tr>
<tr>
<td>MMM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$15.95</td>
<td>$14.35</td>
<td>$14.67</td>
<td>$145.00</td>
<td>$111.4K</td>
<td align="right">870</td>
<td align="right">77</td>
</tr>
<tr>
<td>MMM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$19.1</td>
<td>$17.9</td>
<td>$18.43</td>
<td>$150.00</td>
<td>$106.3K</td>
<td align="right">395</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</p>
<h3>About 3M</h3>
<p>3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.</p>
<p>Having examined the options trading patterns of 3M, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Present Market Standing of 3M</h3>
<ul>
<li>With a trading volume of 1,624,002, the price of MMM is down by -5.28%, reaching $131.01.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 12 days from now.</li>
</ul>
<h3>What Analysts Are Saying About 3M</h3>
<p>Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $150.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Barclays persists with their Overweight rating on 3M, maintaining a target price of $160.<br />
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for 3M, targeting a price of $140. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest 3M options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


3M Options Trading: A Deep Dive into Market Sentiment

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Accenture</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ACN, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 21 uncommon options trades for Accenture.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 38% bullish and 52%, bearish.</p>
<p>Out of all of the special options we uncovered, 15 are puts, for a total amount of $1,175,608, and 6 are calls, for a total amount of $224,120.</p>
<h3>Projected Price Targets</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $230.0 to $350.0 for Accenture over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Accenture's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Accenture's whale activity within a strike price range from $230.0 to $350.0 in the last 30 days. </p>
<h3>Accenture 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1744304430_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ACN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$11.2</td>
<td>$9.4</td>
<td>$9.4</td>
<td>$270.00</td>
<td>$247.2K</td>
<td align="right">225</td>
<td align="right">238</td>
</tr>
<tr>
<td>ACN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$39.3</td>
<td>$39.2</td>
<td>$39.2</td>
<td>$310.00</td>
<td>$196.0K</td>
<td align="right">416</td>
<td align="right">50</td>
</tr>
<tr>
<td>ACN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$5.3</td>
<td>$5.2</td>
<td>$5.2</td>
<td>$230.00</td>
<td>$155.4K</td>
<td align="right">179</td>
<td align="right">299</td>
</tr>
<tr>
<td>ACN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$50.5</td>
<td>$49.6</td>
<td>$50.5</td>
<td>$330.00</td>
<td>$80.8K</td>
<td align="right">416</td>
<td align="right">16</td>
</tr>
<tr>
<td>ACN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/25/25</td>
<td>$8.1</td>
<td>$6.0</td>
<td>$6.8</td>
<td>$285.00</td>
<td>$68.0K</td>
<td align="right">19</td>
<td align="right">100</td>
</tr>
</tbody>
</table>
</p>
<h3>About Accenture</h3>
<p>Accenture is a leading global IT services firm that provides consulting, strategy, and technology and operational services. These services run the gamut from aiding enterprises with digital transformation to procurement services to software system integration. The company provides its IT offerings to a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture employs just under 500,000 people throughout 200 cities in 51 countries.</p>
<p>Following our analysis of the options activities associated with Accenture, we pivot to a closer look at the company's own performance.</p>
<h3>Present Market Standing of Accenture</h3>
<ul>
<li>With a trading volume of 1,691,867, the price of ACN is down by -5.64%, reaching $281.63.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 71 days from now.</li>
</ul>
<h3>Expert Opinions on Accenture</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $387.2.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from RBC Capital continues to hold a Outperform rating for Accenture, targeting a price of $392.<br />
&#x2A; In a positive move, an analyst from Baird has upgraded their rating to Outperform and adjusted the price target to $390.<br />
&#x2A; An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Accenture, which currently sits at a price target of $372.<br />
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Accenture, which currently sits at a price target of $387.<br />
&#x2A; An analyst from Guggenheim has decided to maintain their Buy rating on Accenture, which currently sits at a price target of $395. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Accenture, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


What the Options Market Tells Us About Accenture

<p><strong>Dell Technologies's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) short percent of float has risen 16.06% since its last report. The company recently reported that it has <strong>15.52 million shares sold short</strong>, which is 4.77% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.45 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Dell Technologies Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1744304427_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Dell Technologies has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Dell Technologies's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Dell Technologies's peer group average for short interest as a percentage of float is 8.89%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

DELL

What Does the Market Think About Dell Technologies?

<p>Looking into the current session, <strong>Alibaba Gr Hldgs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>)</strong> shares are trading at $104.56, after a <strong>0.21%</strong> drop. Over the past month, the stock fell by <strong>24.41%</strong>, but over the past year, it actually increased by <strong>46.70%</strong>. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2025/1744304424_0.png" alt="Past Year Chart" /></p>

<h3>A Look at Alibaba Gr Hldgs P/E Relative to Its Competitors</h3>
<p>The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. </p>
<p>Alibaba Gr Hldgs has a lower P/E than the aggregate P/E of <strong>38.4</strong> of the Broadline Retail industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2025/1744304424_1.png" alt="Guage" /></p>

<p>In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes. </p>


Intraday Update

BABA

A Look Into Alibaba Gr Hldgs Inc's Price Over Earnings

<p><strong>Vertiv Holdings's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>) short percent of float has risen 42.95% since its last report. The company recently reported that it has <strong>14.39 million shares sold short</strong>, which is 4.56% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 1.47 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Vertiv Holdings Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1744304422_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Vertiv Holdings has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Vertiv Holdings's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Vertiv Holdings's peer group average for short interest as a percentage of float is 8.92%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Looking Into Vertiv Holdings's Recent Short Interest

<p><strong>PACCAR's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NYSE">PCAR</a>) short percent of float has risen 16.89% since its last report. The company recently reported that it has <strong>11.62 million shares sold short</strong>, which is 2.56% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 4.03 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>PACCAR Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1744304416_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for PACCAR has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing PACCAR's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, PACCAR's peer group average for short interest as a percentage of float is 6.13%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


PCAR

How Do Investors Really Feel About PACCAR?

<p>The <strong>Energy Select Sector SPDR Fund</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NASDAQ">XLE</a>) is trading lower by 6.91% to $76.67 during Thursday&#8217;s session, as investors stepped back from Wednesday's risk-on rally and locked in profits, even as new inflation data came in <a href="https://www.benzinga.com/news/econ-s/25/04/44733390/march-inflation-rate-cools-far-more-than-expected-raises-hopes-for-near-term-fed-rate-cuts">cooler than expected</a>.</p>
<p><strong>What To Know:</strong> After surging around 10% following <strong>President Donald Trump's</strong> surprise 90-day pause on additional tariffs for non-retaliating countries, XLE fell around 5.9% Thursday morning, mirroring a broader market cooldown.</p>
<p>XLE is a sector-focused exchange-traded fund that tracks the performance of U.S. energy companies within the S&amp;P 500. Its top holdings include <strong>Exxon Mobil Corp</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>), <strong>Chevron Corp</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>), <strong>Schlumberger NV</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>), <strong>ConocoPhillips</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) and <strong>Occidental Petroleum Corp</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>)—firms highly sensitive to commodity pricing, global demand expectations and geopolitical developments.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/25/04/44734009/tech-sector-heading-into-a-period-of-mass-uncertainty-amid-tariffs-and-upcoming-earnings-season-says-dan-ives-the-damage-is-real">Tech Sector Entering A Period Of &#8216;Mass Uncertainty&#8217; Amid Tariffs And Upcoming Earnings Season, Says Dan Ives: &#8216;The Damage Is Real&#8217;</a></strong></p>
<p><strong>What Else:</strong> Despite the pullback, Thursday's macroeconomic backdrop was supportive. U.S. consumer prices <a href="https://www.benzinga.com/news/econ-s/25/04/44733390/march-inflation-rate-cools-far-more-than-expected-raises-hopes-for-near-term-fed-rate-cuts">unexpectedly declined in March</a>, with headline inflation falling to 2.4% year-over-year and core inflation easing to 2.8%, both below forecasts. </p>
<p>The CPI even contracted 0.1% month-over-month, the lowest reading since May 2020, suggesting that tariff-related price pressures may be easing rather than accelerating.</p>
<p>However, energy markets faced mixed signals. A sharp 6.3% drop in gasoline prices weighed on the sector outlook, despite increased investor confidence in global trade stability following the tariff reprieve.</p>
<p>XLE's pullback Thursday also likely reflects a combination of profit taking and caution in a sector still tethered to volatile global dynamics, including Chinese demand, OPEC policy and currency fluctuations.</p>
<p>According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, XLE has a 52-week high of $98.97 and a 52-week low of $74.49.</p>


Exxon Mobil And Chevron Among Top Energy Stock Losers Thursday: What's Going On?

<p><a href="https://www.chicagofed.org/publications/speeches/2025/april-10-austan-goolsbee-economic-club-new-york" title="https://www.chicagofed.org/publications/speeches/2025/april-10-austan-goolsbee-economic-club-new-york">https://www.chicagofed.org/publications/speeches/2025/april-10-austan-goolsbee-economic-club-new-york</a></p>


Federal Reserve

Fed's Goolsbee Says Immigration Has Both Supply And Demand Impacts; Reduced Immigration Could Create Job Market Shortages

<p><a href="https://www.youtube.com/watch?v=sk1lGGRgQmk">https://www.youtube.com/watch?v=sk1lGGRgQmk</a></p>


Politics

Global

President Trump Says There Will Be A Transition Cost, Transition Problems On Tariffs But In End Will Be Incredible Thing; U.S. Defense Secretary Hegseth Says We Along With Panama Are Pushing China Out; U.S. Commerce Secretary Lutnick Says Within A Week We Are Going To Start With Trump Gold Card

<p>HC Wainwright &amp; Co.  analyst Douglas Tsao   reiterates Protagonist Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTGX#NASDAQ">PTGX</a>) with a Buy and maintains $80 price target.</p>


Price Target

Reiteration

PTGX

HC Wainwright & Co. Reiterates Buy on Protagonist Therapeutics, Maintains $80 Price Target

<p><a href="https://www.chicagofed.org/publications/speeches/2025/april-10-austan-goolsbee-economic-club-new-york">https://www.chicagofed.org/publications/speeches/2025/april-10-austan-goolsbee-economic-club-new-york</a></p>


Fed's Goolsbee Says Possible Rise In Productivity May Be Tied To Artificial Intelligence Work

WIIM

AXTA

Shares of companies in the broader chemicals sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

<p><a href="https://www.youtube.com/watch?v=sk1lGGRgQmk">https://www.youtube.com/watch?v=sk1lGGRgQmk</a></p>
<p>&nbsp;</p>


LIVE: Watch President Trump Hosts Cabinet Meeting At White House

AGCO

ATMU

CMCO

CVGI

GTES

GTLS

HLIO

JBTM

LECO

MIDD

NDSN

RAIL

TWIN

Shares of machinery companies are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

<p>HC Wainwright &amp; Co.  analyst Ed Arce   reiterates Arcturus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCT#NASDAQ">ARCT</a>) with a Buy and maintains $60 price target.</p>


ARCT

HC Wainwright & Co. Reiterates Buy on Arcturus Therapeutics, Maintains $60 Price Target

<p><a href="https://castor.house.gov/news/documentsingle.aspx?DocumentID=404890">https://castor.house.gov/news/documentsingle.aspx?DocumentID=404890</a></p>
<p>&nbsp;</p>
<p>Today, U.S. Reps. Kathy Castor (FL-14) and Dave Min (CA-47) introduced the&nbsp;Employee Limits ON Profiteering Act&nbsp;(ELON Profiteering Act)&nbsp;that&nbsp;would prevent special government employees like&nbsp;Elon&nbsp;Musk from receiving any federal contracts, grants and awards, similar to prohibitions for most government workers.&nbsp;</p>
<p>&nbsp;</p>


TSLA

'U.S. Reps. Castor, Min Introduce "ELON Profiteering Act" To Outlaw Conflicts Of Interest For Special Employees Like Musk'

CENX

CSTM

SCCO

STLD

Shares of metals stocks are trading lower, pulling back after surging Wednesday following President Trump's tariff pause announcement. The sector has been volatile amid trade war concerns.

Earnings

Press Releases

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Verona Pharma to Present at Jefferies London Healthcare Conference

Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance

Verona Pharma Announces December 2024 Investor Conference Participation

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update

Verona Pharma Announces March 2025 Investor Conference Participation

Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Financing

Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS

Xeris Announces Changes to Its Board of Directors

AGEN

LGND

TVTX

VKTX

XERS

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

HUTCHMED (China) Limited - American Depositary Shares

HUTCHMED (China)

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Johnson & Johnson

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Organon

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pfizer

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Sanofi

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Comments

Verona Pharma

Vendite allo scoperto

Verona Pharma (NASDAQ:VRNA) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO